Clinical trial
Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)
NCT00264147 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00264147 |
|---|---|
| Title | Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) |
| Official title | A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel-Group, 12-Week Study to Assess the Clinically Effective Dose Range of Etoricoxib and to Assess Its Safety and Tolerability in Patients With Rheumatoid Arthritis |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | etoricoxib, Comparator: placebo, Comparator: diclofenac |
| Enrollment | 761 |
| Start date | Jan 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Dec 12, 2005 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: